Reactivation of chromosomally integrated human herpesvirus-6 by telomeric circle formation

PLoS Genet. 2013;9(12):e1004033. doi: 10.1371/journal.pgen.1004033. Epub 2013 Dec 19.

Abstract

More than 95% of the human population is infected with human herpesvirus-6 (HHV-6) during early childhood and maintains latent HHV-6 genomes either in an extra-chromosomal form or as a chromosomally integrated HHV-6 (ciHHV-6). In addition, approximately 1% of humans are born with an inheritable form of ciHHV-6 integrated into the telomeres of chromosomes. Immunosuppression and stress conditions can reactivate latent HHV-6 replication, which is associated with clinical complications and even death. We have previously shown that Chlamydia trachomatis infection reactivates ciHHV-6 and induces the formation of extra-chromosomal viral DNA in ciHHV-6 cells. Here, we propose a model and provide experimental evidence for the mechanism of ciHHV-6 reactivation. Infection with Chlamydia induced a transient shortening of telomeric ends, which subsequently led to increased telomeric circle (t-circle) formation and incomplete reconstitution of circular viral genomes containing single viral direct repeat (DR). Correspondingly, short t-circles containing parts of the HHV-6 DR were detected in cells from individuals with genetically inherited ciHHV-6. Furthermore, telomere shortening induced in the absence of Chlamydia infection also caused circularization of ciHHV-6, supporting a t-circle based mechanism for ciHHV-6 reactivation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chlamydia trachomatis / pathogenicity
  • Chlamydia trachomatis / virology
  • Chlamydiaceae Infections / genetics
  • Chlamydiaceae Infections / pathology
  • Chlamydiaceae Infections / virology
  • Chromosomes, Human / genetics*
  • DNA, Viral / genetics*
  • Genome, Viral
  • Herpesvirus 6, Human / genetics*
  • Humans
  • Telomere / genetics*
  • Telomere Shortening / genetics
  • Virus Integration / genetics
  • Virus Latency / genetics
  • Virus Replication / genetics

Substances

  • DNA, Viral

Grants and funding

This work was supported by the German Federal Ministry of Education and Research, grant 0315834 A (TR), grant RU 631/5-1 AOBJ: 554592 German-Israeli Project Cooperation from the German Research Foundation (DFG)(TR), and grant B-192 from the Interdisciplinary Center for Clinical Research of the University of Wuerzburg (TR). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.